278 related articles for article (PubMed ID: 16550162)
1. Cyclin D1: polymorphism, aberrant splicing and cancer risk.
Knudsen KE; Diehl JA; Haiman CA; Knudsen ES
Oncogene; 2006 Mar; 25(11):1620-8. PubMed ID: 16550162
[TBL] [Abstract][Full Text] [Related]
2. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.
Comstock CE; Augello MA; Benito RP; Karch J; Tran TH; Utama FE; Tindall EA; Wang Y; Burd CJ; Groh EM; Hoang HN; Giles GG; Severi G; Hayes VM; Henderson BE; Le Marchand L; Kolonel LN; Haiman CA; Baffa R; Gomella LG; Knudsen ES; Rui H; Henshall SM; Sutherland RL; Knudsen KE
Clin Cancer Res; 2009 Sep; 15(17):5338-49. PubMed ID: 19706803
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
[TBL] [Abstract][Full Text] [Related]
7. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.
Gupta VK; Feber A; Xi L; Pennathur A; Wu M; Luketich JD; Godfrey TE
Clin Cancer Res; 2008 Dec; 14(23):7804-12. PubMed ID: 19047108
[TBL] [Abstract][Full Text] [Related]
8. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.
Tashiro E; Tsuchiya A; Imoto M
Cancer Sci; 2007 May; 98(5):629-35. PubMed ID: 17359287
[TBL] [Abstract][Full Text] [Related]
9. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
Gautschi O; Ratschiller D; Gugger M; Betticher DC; Heighway J
Lung Cancer; 2007 Jan; 55(1):1-14. PubMed ID: 17070615
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
Millar EK; Dean JL; McNeil CM; O'Toole SA; Henshall SM; Tran T; Lin J; Quong A; Comstock CE; Witkiewicz A; Musgrove EA; Rui H; Lemarchand L; Setiawan VW; Haiman CA; Knudsen KE; Sutherland RL; Knudsen ES
Oncogene; 2009 Apr; 28(15):1812-20. PubMed ID: 19287456
[TBL] [Abstract][Full Text] [Related]
13. Nuclear cyclin D1: an oncogenic driver in human cancer.
Kim JK; Diehl JA
J Cell Physiol; 2009 Aug; 220(2):292-6. PubMed ID: 19415697
[TBL] [Abstract][Full Text] [Related]
14. Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.
Li Z; Wang C; Jiao X; Katiyar S; Casimiro MC; Prendergast GC; Powell MJ; Pestell RG
J Biol Chem; 2008 Mar; 283(11):7007-15. PubMed ID: 18180298
[TBL] [Abstract][Full Text] [Related]
15. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
[TBL] [Abstract][Full Text] [Related]
16. Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity.
Sanchez G; Delattre O; Auboeuf D; Dutertre M
Cell Cycle; 2008 Aug; 7(15):2299-305. PubMed ID: 18677114
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1, cancer progression, and opportunities in cancer treatment.
Qie S; Diehl JA
J Mol Med (Berl); 2016 Dec; 94(12):1313-1326. PubMed ID: 27695879
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
19. The cyclin D1b splice variant: an old oncogene learns new tricks.
Knudsen KE
Cell Div; 2006 Jul; 1():15. PubMed ID: 16863592
[TBL] [Abstract][Full Text] [Related]
20. BAF57/SMARCE1 Interacting with Splicing Factor SRSF1 Regulates Mechanical Stress-Induced Alternative Splicing of Cyclin D1.
Feng J; Xu X; Fan X; Yi Q; Tang L
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33670012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
